Zymeworks Set to Join Russell 3000®, Russell 2000®, and Russell Microcap® Indexes

VANCOUVER, British Columbia, June 26, 2023 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today announced that it is set to join both the Russell 3000®, Ru...

Related Keywords

Delaware ,United States ,Ireland ,Vancouver ,British Columbia ,Canada ,United Kingdom ,British ,Diana Papove ,Kenneth Galbraith ,Beigene Ltd ,Zymeworks Inc ,Jazz Pharmaceuticals Ireland ,Nasdaq ,Corporate Communications ,Securities Exchange ,Russell Microcap ,Chief Executive Officer ,Jazz Pharmaceuticals Ireland Limited ,Securities Act ,Securities Exchange Act ,Russell Microcap Indexes ,Zymework Quarterly Report ,Although Zymeworks ,Media Inquiries ,